CervoMed Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
CervoMed Inc. (CRVO) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $2.10 million as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2018-11-13
- 2018-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.10M.
- 2018-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.50M.
- 2016-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.10M.
- 2015-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.68M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2018-09-30 | $2.10M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.50M 10-Q · filed 2018-08-10 |
| 2016-03-31 | $2.10M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $2.68M 10-K · filed 2016-03-25 |
| 2015-09-30 | $3.16M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $3.64M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $5.17M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $6.11M 10-K · filed 2015-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |